RAB4B antibody
Principal name
RAB4B antibody
Alternative names for RAB4B antibody
Rab-4B, PP1596, Ras-related protein Rab-4B
Ncbi ID
9606, NP_057238, NP_057238.3, NM_029391, NM_017355, NM_016154, NP_083667.1
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of RAB4B antibody
- Kit Component:
- - KN314377G1, Rab4b gRNA vector 1 in pCas-Guide vector
- KN314377G2, Rab4b gRNA vector 2 in pCas-Guide vector
- KN314377D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP308302 | RAB4B |
||||
| Recombinant protein of human RAB4B, member RAS oncogene family (RAB4B) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR202336L2V | Lenti ORF particles, Rab4b (GFP-tagged) - Mouse RAB4B, member RAS oncogene family (Rab4b), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR202336L1V | Lenti ORF particles, Rab4b (Myc-DDK-tagged) - Mouse RAB4B, member RAS oncogene family (Rab4b), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR206714L2V | Lenti ORF particles, Rab4b (GFP-tagged ORF) - Rat RAB4B, member RAS oncogene family (Rab4b), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR206714L1V | Lenti ORF particles, Rab4b (Myc-DDK-tagged ORF) - Rat RAB4B, member RAS oncogene family (Rab4b), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||